Keyphrases
AIDS Patients
6%
AIDS/HIV
28%
Antibiotic Resistance
5%
Antibiotics
7%
Antiretroviral Therapy
14%
Arthritis Patients
5%
Body Mass Index
6%
Breast Cancer Patients
5%
C-reactive Protein
6%
CagA
10%
Chronic Kidney Disease
21%
Chronic Kidney Disease Patients
16%
Chronic Myeloid Leukemia
5%
Clarithromycin
5%
Clinical Characteristics
5%
Clinical Manifestations
6%
Clinical Outcomes
6%
Co-infection
5%
Comorbidity
7%
Confidence Interval
5%
COVID-19
53%
COVID-19 Pandemic
7%
COVID-19 Patients
9%
COVID-19 Vaccine
5%
CRF01_AE
11%
Critically Ill COVID-19 Patients
5%
D-dimer
6%
Dengue Fever
6%
Disease Activity
9%
Drug Resistance mutations
9%
Dyspepsia
5%
East Asia
5%
East Java Indonesia
8%
Estimated Glomerular Filtration Rate
5%
Ethyl Acetate
6%
Fever
5%
Frailty
8%
Fungus Comb
5%
Gastric Cancer
9%
Gene Polymorphism
5%
General Hospital
10%
Genotype
6%
Helicobacter Pylori (H. pylori)
48%
Helicobacter Pylori Infection
27%
Hemodialysis
12%
Hemodialysis Patients
8%
Hemoglobin A1c (HbA1c)
6%
Hepatitis B
5%
Hepatitis B Virus
6%
High-sensitivity C-reactive Protein (hs-CRP)
5%
HIV Patients
11%
Human Immunodeficiency Virus Type 1 (HIV-1)
23%
Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome
5%
Hypertension
11%
Indomalaya
5%
Indonesia
100%
Indonesian
17%
Infected Individual
5%
Inflammation
7%
Inflammatory Cytokines
5%
Insulin Resistance
6%
Intact Parathyroid Hormone (iPTH)
6%
Interleukin-6
9%
Macrotermes Gilvus Hagen
5%
Maintenance Hemodialysis Patients
5%
Medical Records
7%
Meta-analysis
19%
Nave
7%
No Significant Difference
5%
Non-dialysis Chronic Kidney Disease
5%
Non-Hodgkin Lymphoma
5%
Obesity
5%
Oxidative Stress
7%
Patients with Diabetes Mellitus
5%
Proton Pump Inhibitors
5%
Psoriatic Arthritis
6%
Pulmonary Tuberculosis
5%
Referral Hospital
6%
Risk Factors
11%
Sarcopenia
7%
Sepsis
6%
Spondyloarthritis
6%
Surabaya
53%
Systematic Meta-analysis
15%
Systemic Lupus Erythematosus
6%
Termites
5%
Tuberculosis
6%
Type 1 Diabetes Mellitus (T1DM)
12%
Type 2 Diabetes Mellitus (T2DM)
19%
Type 2 Diabetes Mellitus Patients
7%
Type 2 Diabetic Patients
14%
Vaccination
5%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
7%
Antibiotics
7%
Antimicrobial Resistance
7%
Antivirus Agent
5%
Biological Marker
6%
C Reactive Protein
12%
Cardiovascular Disease
6%
Chemotherapy
8%
Chronic Kidney Failure
22%
Clarithromycin
8%
Cohort Study
5%
Comorbidity
10%
Coronavirinae
32%
COVID-19 Vaccine
6%
Cross-Sectional Study
15%
D Dimer
6%
Dengue
7%
Dengue Virus
6%
Diabetes Mellitus
16%
Disease Activity
8%
Diseases
60%
Drug Resistance
13%
Frailty
7%
Gastritis
5%
Helicobacter Infection
10%
Helicobacter Pylori
37%
Hemodialysis
22%
Hemoglobin A1c
6%
HIV
38%
Human Immunodeficiency Virus 1
9%
Human Immunodeficiency Virus Infection
5%
Infection
34%
Inflammation
12%
Interleukin 6
8%
Levofloxacin
5%
Metronidazole
8%
Mortality Rate
5%
Non Insulin Dependent Diabetes Mellitus
19%
Nonhodgkin Lymphoma
6%
Prevalence
25%
Retrospective Study
10%
Sarcopenia
7%
SARS Coronavirus
11%
Sepsis
7%
Spondylarthritis
6%
Virus Infection
5%
Vitamin D
5%
Medicine and Dentistry
Abdominal Cancer
8%
Antiretroviral Therapy
5%
Biological Marker
6%
C Reactive Protein
5%
Case Presentation
6%
Chronic Kidney Disease
18%
Chronic Myelogenous Leukemia
5%
Comorbidity
7%
COVID-19
47%
COVID-19 Vaccine
5%
Cross Sectional Study
11%
Diabetes
5%
Diabetes Mellitus
16%
Diagnosis
11%
Diseases
19%
Drug Resistance
6%
Health Care Cost
5%
Helicobacter Infection
8%
Helicobacter Pylori
29%
Hemodialysis
10%
Human Immunodeficiency Virus
17%
Human Immunodeficiency Virus 1
8%
Infection
29%
Liver Cirrhosis
6%
Lymphocyte
8%
Maturity Onset Diabetes of the Young
9%
Meta-Analysis
13%
Mixed Infection
5%
Non-Hodgkin Lymphoma
5%
Patient with Diabetes
6%
Platelet
5%
Prevalence
17%
Retrospective Study
8%
Sepsis
6%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Stomach Acid
5%
Systematic Review
16%